Guideline concordant opioid therapy in Veterans receiving VA and community care.
Humans
United States
Male
Guideline Adherence
/ statistics & numerical data
Analgesics, Opioid
/ therapeutic use
Veterans
/ statistics & numerical data
Female
Middle Aged
United States Department of Veterans Affairs
Community Health Services
Aged
Practice Guidelines as Topic
Opioid-Related Disorders
/ drug therapy
Adult
District of Columbia
Baltimore
Veterans Health Services
/ statistics & numerical data
Concordant care
Drug adherence
Mono vs dual-system
Opioid therapy disorder
Journal
BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677
Informations de publication
Date de publication:
26 Oct 2024
26 Oct 2024
Historique:
received:
17
05
2024
accepted:
10
10
2024
medline:
26
10
2024
pubmed:
26
10
2024
entrez:
25
10
2024
Statut:
epublish
Résumé
Guideline concordant opioid therapy is a key part of the concerted effort to address the opioid crisis in the United States. The study aimed to compare the rates of guideline concordant care between veterans who solely used VA services (mono users) and veterans who used both VA services and community care (dual-system users). We used electronic health record data from the Washington DC and Baltimore VA Medical Centers from 2015 to 2019. We provided descriptive statistics as well as generalized estimating equations models to find associations between mono vs. dual-system users and each guideline outcome, controlling for demographic factors and comorbid conditions. The study found that overall rates of guideline concordant care were high in both mono and dual-system users with over 90% adherence rates for the majority of recommendations. However, there were variations in adherence to specific guidelines, with urine drug screening at initiation being the least commonly followed recommendation (8.9% of mono-user opioid initiators and 11.2% of dual-user initiators). This study also found that there was no consistent pattern of higher guideline adherence in mono vs. dual-system users but did show that through the course of this study (2015-2019) overall rates of guideline concordance increased. Future research will explore additional guideline recommendations and potential coordination issues among dual-system users.
Identifiants
pubmed: 39456008
doi: 10.1186/s12913-024-11742-1
pii: 10.1186/s12913-024-11742-1
doi:
Substances chimiques
Analgesics, Opioid
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1284Subventions
Organisme : United States Veteran Affairs HSRD IIR
ID : HX003100-01A2
Organisme : United States Veteran Affairs HSRD IIR
ID : HX003100-01A2
Organisme : United States Veteran Affairs HSRD IIR
ID : HX003100-01A2
Organisme : United States Veteran Affairs HSRD IIR
ID : HX003100-01A2
Organisme : United States Veteran Affairs HSRD IIR
ID : HX003100-01A2
Organisme : United States Veteran Affairs HSRD IIR
ID : HX003100-01A2
Organisme : United States Veteran Affairs HSRD IIR
ID : HX003100-01A2
Organisme : United States Veteran Affairs HSRD IIR
ID : HX003100-01A2
Organisme : United States Veteran Affairs HSRD IIR
ID : HX003100-01A2
Organisme : United States Veteran Affairs HSRD IIR
ID : HX003100-01A2
Organisme : United States Veteran Affairs HSRD IIR
ID : HX003100-01A2
Organisme : United States Veteran Affairs HSRD IIR
ID : HX003100-01A2
Organisme : United States Veteran Affairs HSRD IIR
ID : HX003100-01A2
Organisme : United States Veteran Affairs HSRD IIR
ID : HX003100-01A2
Organisme : United States Veteran Affairs HSRD IIR
ID : HX003100-01A2
Organisme : United States Veteran Affairs HSRD IIR
ID : HX003100-01A2
Organisme : United States Veteran Affairs HSRD IIR
ID : HX003100-01A2
Informations de copyright
© 2024. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.
Références
Alpert A, Evans WN, Lieber EMJ, Powell D. Origins of the Opioid Crisis and its Enduring impacts. Q J Econ. 2022;137(2):1139–79.
doi: 10.1093/qje/qjab043
pubmed: 35832727
Sade RM. Introduction: opioid controversies: the Crisis - causes and solutions. J Law Med Ethics. 2020;48(2):238–40.
doi: 10.1177/1073110520935334
pubmed: 32631192
Volkow ND, Blanco C. The changing opioid crisis: development, challenges and opportunities. Mol Psychiatry. 2021;26(1):218–33.
doi: 10.1038/s41380-020-0661-4
pubmed: 32020048
DeWeerdt S. Tracing the US opioid crisis to its roots. Nature. 2019;573(7773):S10–2.
doi: 10.1038/d41586-019-02686-2
pubmed: 31511672
Morland R. Evolution of the national opioid crisis. Nursing. 2019;49(5):51–6.
doi: 10.1097/01.NURSE.0000554613.10524.54
pubmed: 31022031
Office CB, The Opioid Crisis and Recent Federal Policy Responses. Congressional Budget Office. 2022. https://www.cbo.gov/system/files/2022-09/58221-opioid-crisis.pdf .
Wide-ranging online data for epidemiologic research (WONDER). CDC, National Center for Health Statistics. 2022. http://wonder.cdc.gov .
Biesboer EA, Al Tannir AH, Karam BS, Tyson K, Peppard WJ, Morris R, et al. A Prescribing Guideline decreases postoperative opioid prescribing in emergency general surgery. J Surg Res. 2024;293:607–12.
doi: 10.1016/j.jss.2023.09.012
pubmed: 37837815
Gangal A, Stoff B, Blalock T. The 2022 CDC opioid prescription guideline update: relevant recommendations and future considerations. JAAD Int. 2023;13:48–9.
doi: 10.1016/j.jdin.2023.07.006
pubmed: 37674776
pmcid: 10477793
Langford AV, Lin CC, Bero L, Blyth FM, Doctor J, Holliday S, et al. Clinical practice guideline for deprescribing opioid analgesics: summary of recommendations. Med J Aust. 2023;219(2):80–9.
doi: 10.5694/mja2.52002
pubmed: 37356051
Lindros SH, Warren JA, Carbonell AM 2nd, WSt C, Floyd SB. Implementation of a patient-tailored opioid prescribing Guideline in ventral hernia surgery. J Surg Res. 2023;282:109–17.
doi: 10.1016/j.jss.2022.09.021
pubmed: 36270120
Benzon HT, Sun EC, Chou R. The Opioid Crisis, Centers for Disease Control Opioid Guideline, and Naloxone Coprescription for patients at risk for opioid overdose. Anesth Analg. 2022;135(1):21–5.
doi: 10.1213/ANE.0000000000006029
pubmed: 35709441
Langnas E, Bishara A, Croci R, Rodriguez-Monguio R, Wick EC, Chen CL, et al. Opioid prescribing practices at hospital discharge for surgical patients before and after the Centers for Disease Control and Prevention’s 2016 opioid prescribing guideline. BMC Anesthesiol. 2022;22(1):141.
doi: 10.1186/s12871-022-01678-6
pubmed: 35546657
pmcid: 9097447
Anne S, Mims JW, Tunkel DE, Rosenfeld RM, Boisoneau DS, Brenner MJ, et al. Clinical practice Guideline: opioid prescribing for Analgesia after Common Otolaryngology operations. Otolaryngol Head Neck Surg. 2021;164(2suppl):S1–42.
pubmed: 33822668
The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder. 2020 focused update. J Addict Med. 2020;14(2S Suppl 1):1–91.
Binswanger IA, Joseph N, Hanratty R, Gardner EM, Durfee J, Narwaney KJ, et al. Novel Opioid Safety Clinic Initiative to deliver Guideline-Concordant Chronic Opioid Therapy in Primary Care. Mayo Clin Proc Innov Qual Outcomes. 2018;2(4):309–16.
doi: 10.1016/j.mayocpiqo.2018.09.005
pubmed: 30560232
pmcid: 6260499
Weber C, Reinecke H, Simon M, Lange K, Sorgatz H. [Opioid guidelines: yesterday and today: current guideline recommendations for chronic non-tumor pain]. Anaesthesist. 2012;61(7):625–9.
doi: 10.1007/s00101-012-2035-z
pubmed: 22782129
Rosenberg JM, Bilka BM, Wilson SM, Spevak C. Opioid therapy for Chronic Pain: overview of the 2017 US Department of Veterans Affairs and US Department of Defense Clinical Practice Guideline. Pain Med. 2018;19(5):928–41.
doi: 10.1093/pm/pnx203
pubmed: 29025128
Macedo F, Annaswamy T, Coller R, Buelt A, Glotfelter MA, Heideman PW. THE DIAGNOSIS AND TREATMENT OF LOW BACK PAIN. : Synopsis of the 2021 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline. Am J Phys Med Rehabil. 2023;103(4):350-5.
Sandbrink F, Murphy JL, Johansson M, Olson JL, Edens E, Clinton-Lont J, et al. The Use of opioids in the management of Chronic Pain: Synopsis of the 2022 updated U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline. Ann Intern Med. 2023;176(3):388–97.
doi: 10.7326/M22-2917
pubmed: 36780654
Billings JD, Huynh V, Leonard LD, Kovar A, Jones TS, Cumbler E, et al. Addressing an epidemic: improving guideline-concordant opioid prescribing in surgical patients. Surgery. 2022;172(5):1407–14.
doi: 10.1016/j.surg.2022.06.033
pubmed: 36088172
U.S. Department of Veteran Affairs. VA reduces prescription opioid use by 64% during past eight years. 2020. https://news.va.gov/press-room/va-reduces-prescription-opioid-use-by-64-during-past-eight-years . Accessed 5 Oct 2024.
Moyo P, Zhao X, Thorpe CT, Thorpe JM, Sileanu FE, Cashy JP, et al. Dual receipt of prescription opioids from the Department of Veterans affairs and Medicare Part D and prescription opioid overdose death among veterans: a nested case-control study. Ann Intern Med. 2019;170(7):433–42.
doi: 10.7326/M18-2574
pubmed: 30856660
pmcid: 6736692
Becker WC, Fenton BT, Brandt CA, Doyle EL, Francis J, Goulet JL, et al. Multiple sources of prescription payment and Risky Opioid Therapy among veterans. Med Care. 2017;55(7 Suppl 1):S33–6.
doi: 10.1097/MLR.0000000000000722
pubmed: 28410338
Goulet J, Cheng Y, Becker W, Brandt C, Sandbrink F, Workman TE, et al. Opioid use and opioid use disorder in mono and dual-system users of veteran affairs medical centers. Front Public Health. 2023;11:1148189.
doi: 10.3389/fpubh.2023.1148189
pubmed: 37124766
pmcid: 10141670
Goulet JL, Kerns RD, Bair M, Becker WC, Brennan P, Burgess DJ, et al. The musculoskeletal diagnosis cohort: examining pain and pain care among veterans. Pain. 2016;157(8):1696–703.
doi: 10.1097/j.pain.0000000000000567
pubmed: 27023420
pmcid: 4949131
Ghisletta P, Spini D. An introduction to generalized estimating equations and an application to assess selectivity effects in a longitudinal study on very old individuals. J Educational Behav Stat. 2004;29(4):421–37.
doi: 10.3102/10769986029004421
Deo N, Johnson E, Kancharla K, O’Horo JC, Kashyap R. Instant gratification as a method to promote Physician Practice Guideline Adherence: a systematic review. Cureus. 2020;12(7):e9381.
pubmed: 32850248
pmcid: 7445093
Arts DL, Voncken AG, Medlock S, Abu-Hanna A, van Weert HC. Reasons for intentional guideline non-adherence: a systematic review. Int J Med Inf. 2016;89:55–62.
doi: 10.1016/j.ijmedinf.2016.02.009